Velcade (Bortezomib) Consolidation After Transplant

Clinical trial NCT01539083 · COMPLETED

Trial details

NCT number: NCT01539083
Sponsor: Janssen Scientific Affairs, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2012-01-13
Primary completion: 2015-12-30
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.